Respiratorius AB Logo

Respiratorius AB

Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.

RESP | SPGR

Overview

Corporate Details

ISIN(s):
SE0004550192 (+2 more)
LEI:
5493001YRVZ5XYFEE615
Country:
Sweden
Address:
Scheeletorget 1, 223 81 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Respiratorius AB is a pharmaceutical research and development company focused on creating innovative drug candidates. The company's primary strategic focus is on oncology, specifically developing treatments for aggressive forms of cancer like diffuse large B-cell lymphoma (DLBCL). Its lead project, VAL001, is a drug candidate intended to be used as a pre-treatment to enhance the efficacy of standard therapies. While historically involved in developing drugs for respiratory diseases such as COPD and severe asthma, Respiratorius now concentrates its efforts on its cancer pipeline. The company aims to advance its projects through clinical development and subsequent commercialization via strategic partnerships and licensing agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Respiratorius AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Respiratorius AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Respiratorius AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-12-06 Johan Drott Other Buy 1,120 N/A

Peer Companies

Company Country Ticker View
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan 4886
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan 4503

Talk to a Data Expert

Have a question? We'll get back to you promptly.